openPR Logo
Press release

Deadline in Lawsuit for Investors in shares of Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) on March 16th coming up

02-20-2020 04:05 PM CET | Politics, Law & Society

Press release from: Shareholders Foundation

A Deadline is coming up on March 16, 2020 in the lawsuit for certain investors in Portola Pharmaceuticals, Inc. (NASDAQ: PTLA).

A Deadline is coming up on March 16, 2020 in the lawsuit for certain investors in Portola Pharmaceuticals, Inc. (NASDAQ: PTLA).

The Shareholders Foundation announced that a deadline is coming up on March 16, 2020in the lawsuit filed for certain investors of Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) over alleged securities laws violations by Portola Pharmaceuticals, Inc.

Investors who purchased shares of Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) have certain options and there are strict and short deadlines running. Deadline: March 16, 2020. NASDAQ: PTLA stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges on behalf of purchasers of Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) common shares between November 5, 2019 and January 9, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between November 5, 2019 and January 9, 2020, the Defendants failed to disclose to investors that Portola's internal control over financial reporting regarding reserve for product returns was not effective, that Portola was shipping longer-dated product with 36-month shelf life, that Portola had not established adequate reserve for returns of prior shipments of short-dated product, that, as a result, Portola was reasonably likely to need to "catch up" on accounting for return reserves, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline in Lawsuit for Investors in shares of Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) on March 16th coming up here

News-ID: 1939839 • Views:

More Releases from Shareholders Foundation

Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to recover losses
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover losses
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc.. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Malvern, PA based Ocugen, Inc., a
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV
Investigation announced for Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) over possible Violations of Securities Laws
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for Portola

Apixaban Market Determine a Spectacular Expansion And Productive Impact 2022-202 …
𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 released a new market study on 2022-2028 Apixaban Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The global research report delivers an in-depth watch on leading competitors with strategic analysis, small and macro business trends and eventualities, valuation analysis and a holistic summary within the forecast amount. Its knowledge and in-depth reports specializing in primary
Investigation for Long-Term Investors in shares of Portola Pharmaceuticals, Inc. …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Portola Pharmaceuticals, Inc.. Investors who are current long term investors in Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: PTLA stocks follows a lawsuit filed against Portola
Lawsuit filed for Investors in shares of Portola Pharmaceuticals, Inc. (NASDAQ: …
An investor, who purchased shares of Portola Pharmaceuticals, Inc. (NASDAQ: PTLA), filed a lawsuit over alleged Securities Laws violations by Portola Pharmaceuticals, Inc.. Investors who purchased shares of Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) have certain options and for certain investors are short and strict deadlines running. Deadline: March 16, 2020. NASDAQ: PTLA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. San Francisco, CA based Portola Pharmaceuticals,
Global Cardiovascular Drugs Market Competitive Major Vendors – Bayer, Amgen, M …
Researchmoz added Most up-to-date research on "Global Cardiovascular Drugs Market Research Report 2019" to its huge collection of research reports. Cardiovascular Drugs and Therapy is a bimonthly peer-reviewed medical journal covering pharmacotherapy as it relates to cardiology. It was established in 1987 and is published by Springer Science+Business Media on behalf of the International Society of Cardiovascular Pharmacotherapy, of which it is the official journal. The editors-in-chief are Willem J. Remme
Allergic Conjunctivitis Market 2025: Key Major Players are Santen Pharmaceutical …
ReportsnReports.com adds "Global Allergic Conjunctivitis Market, Patients, Treated Patients, by Countries (India, China, Japan, US, UK, etc), Disease Type (SAC, PAC, VKC, AKC, GPC), Drugs Profile (Zerviate, OTX-DP, ADX-102, PRT-2761, etc) Companies, Growth Drivers & Challenges" report to its research store. Access this Global Allergic Conjunctivitis Market report at https://www.reportsnreports.com/reports/1899647-global-allergic-conjunctivitis-market-patients-treated-patients-by-countries-india-china-japan-us-uk-etc-disease-type-sac-pac-vkc-akc-gpc-drugs-profile-zerviate-otx-dp-adx-102-prt-2761-etc-co-challenges.html. Allergic conjunctivitis is a kind of eye disease in which it affect the eye surfaces and are commonly associated to immune-mediated
Global Antidote Market 2018 Key Players: Boehringer Ingelheim Pharmaceuticals, A …
Antidote Market: WiseGuyReports.com adds “Antidote Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting 2025” reports tits database. Executive Summary This report studies the global market size of Antidote in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antidote in these regions. This research report categorizes the global Antidote market by players/brands, region, type and application. This report